Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: ICS withdrawal; Other: Usual care
Sponsors: Radboud University; Novartis; Boehringer Ingelheim
Recruiting – verified February 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days